◀ Back to TP53
BRCA2 — TP53
Pathways - manually collected, often from reviews:
Protein-Protein interactions - manually collected from original source literature:
Studies that report less than 10 interactions are marked with *
-
IRef Biogrid Interaction:
BRCA2
—
TP53
(physical association, affinity chromatography technology)
Dong et al., Mol Cell 2003
-
IRef Biogrid Interaction:
BRCA2
—
TP53
(association, biochemical)
Dong et al., Mol Cell 2003
-
IRef Biogrid Interaction:
BRCA2
—
TP53
(physical association, affinity chromatography technology)
Marmorstein et al., Proc Natl Acad Sci U S A 1998*
-
IRef Dip Interaction:
BRCA2
—
TP53
(direct interaction, pull down)
Rajagopalan et al., Proc Natl Acad Sci U S A 2010*
-
IRef Dip Interaction:
BRCA2
—
TP53
(direct interaction, coimmunoprecipitation)
Marmorstein et al., Proc Natl Acad Sci U S A 1998*
-
IRef Dip Interaction:
BRCA2
—
TP53
(direct interaction, classical fluorescence spectroscopy)
Rajagopalan et al., Proc Natl Acad Sci U S A 2010*
-
IRef Dip Interaction:
BRCA2
—
TP53
(direct interaction, nuclear magnetic resonance)
Rajagopalan et al., Proc Natl Acad Sci U S A 2010*
-
IRef Dip Interaction:
BRCA2
—
TP53
(direct interaction, isothermal titration calorimetry)
Rajagopalan et al., Proc Natl Acad Sci U S A 2010*
-
IRef Ophid Interaction:
BRCA2
—
TP53
(aggregation, interologs mapping)
Brown et al., Bioinformatics 2005
Text-mined interactions from Literome
Wang et al., Cancer Res 2001
:
Surprisingly, down-regulation of
BRCA2 by UV does not
require functional
p53 , which has been suggested to be required for the down-regulation of BRCA1 and BRCA2 mRNAs by DNA damaging agents
Wu et al., J Biol Chem 2003
:
Thus,
BRCA2 levels in the cell are regulated by three independent mechanisms in a
p53 dependent manner
Tannenbaum et al., International journal of biological sciences 2007
:
Increased expression of
p53 in the mimicked heterozygous cells was observed, perhaps in
response to
BRCA2 deficiency
Rajagopalan et al., Proc Natl Acad Sci U S A 2010
:
Overexpression of
BRCA2 and BRCA2 ( CTD )
suppressed the transcriptional activity of
p53 with a concomitant reduction in the expression of p53-target genes such as Bax and p21